Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120760774 | 12076077 | 4 | F | 201510 | 20160923 | 20160215 | 20160925 | EXP | FR-ROCHE-1709887 | ROCHE | 44.00 | YR | F | Y | 0.00000 | 20160926 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120760774 | 12076077 | 1 | PS | VALIUM | DIAZEPAM | 1 | Unknown | 13263 | |||||||||||
| 120760774 | 12076077 | 2 | SS | VALDOXAN | AGOMELATINE | 1 | Oral | 0 | |||||||||||
| 120760774 | 12076077 | 3 | SS | XEROQUEL | QUETIAPINE FUMARATE | 1 | Unknown | 0 | |||||||||||
| 120760774 | 12076077 | 4 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | 0 | 2 | DF | TABLET | ||||||||
| 120760774 | 12076077 | 5 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | 0 | 1 | DF | TABLET | ||||||||
| 120760774 | 12076077 | 6 | SS | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 120760774 | 12076077 | 7 | SS | STILNOX | ZOLPIDEM TARTRATE | 1 | Unknown | 0 | |||||||||||
| 120760774 | 12076077 | 8 | SS | LOXAPAC | LOXAPINE SUCCINATE | 1 | Unknown | 0 | |||||||||||
| 120760774 | 12076077 | 9 | SS | NOCTAMIDE | LORMETAZEPAM | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120760774 | 12076077 | 1 | Product used for unknown indication |
| 120760774 | 12076077 | 2 | Product used for unknown indication |
| 120760774 | 12076077 | 3 | Product used for unknown indication |
| 120760774 | 12076077 | 4 | Product used for unknown indication |
| 120760774 | 12076077 | 6 | Product used for unknown indication |
| 120760774 | 12076077 | 7 | Product used for unknown indication |
| 120760774 | 12076077 | 8 | Product used for unknown indication |
| 120760774 | 12076077 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120760774 | 12076077 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120760774 | 12076077 | Cholestasis | |
| 120760774 | 12076077 | Gamma-glutamyltransferase increased | |
| 120760774 | 12076077 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120760774 | 12076077 | 1 | 2013 | 0 | ||
| 120760774 | 12076077 | 2 | 2013 | 0 | ||
| 120760774 | 12076077 | 3 | 2013 | 0 | ||
| 120760774 | 12076077 | 4 | 2013 | 0 | ||
| 120760774 | 12076077 | 6 | 2013 | 0 |